|
Medicamentos Oncológicos |
Ánalise farmacogenética para medicamentos de uso oncológico. |
ABCB1, ADH1B, BCHE, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, CYP4F2, DPYD, G6PD, HLADQB1, NAT2, NUDT15, TPMT, UGT1A1, UGT1A3, UGT1A4, UGT2B7, UGT2B15, VKORC1 |
|
Leucodistrofia e Leucoencefalopatia |
Painel por Sequenciamento de Próxima Geração |
AARS, AARS2, ABAT, ABCD1, ACOX1, ADAR, AIMP1, ALDH3A2, ARSA, ASPA, AUH, B3GALNT2, BCAP31, BOLA3, C11ORF73, CLCN2, CLN6, COL4A1, CSF1R, CTC1, CYP27A1, DAG1, DARS, DARS2, EARS2, EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5, FA2H, FAM126A, FBXL4, FOLR1, GALC, GBE1, GCDH, GFAP, GJC2, GLRX5, HEPACAM, HIKESHI, HSD17B4, HSPD1, HTRA1, IFIH1, ISCA2, L2HGDH, LAMB1, LIAS, LMNB1, MARS2, MLC1, MRPS22, NADK2, NOTCH3, PC, PEX1, PLEKHG2, PLP1, POLR1C, POLR3A, POLR3B, PSAP, PYCR2, RARS, RNASEH2A, RNASEH2C, RNASET2, RPIA, SAMHD1, SCP2, SDHA, SDHAF1, SDHD, SLC16A2, SLC17A5, SLC25A12, SOX10, SUMF1, TBCK, TMEM70, TREM2, TREX1, TUBB4A, TUFM, TYMP, TYROBP, UGT1A1, VPS11 |
